FR2877573B1 - Nouvelles compositions pharmaceutiques et leurs utilisations pour lutter contre les differentes formes d'accoutumance aux drogues - Google Patents

Nouvelles compositions pharmaceutiques et leurs utilisations pour lutter contre les differentes formes d'accoutumance aux drogues

Info

Publication number
FR2877573B1
FR2877573B1 FR0411810A FR0411810A FR2877573B1 FR 2877573 B1 FR2877573 B1 FR 2877573B1 FR 0411810 A FR0411810 A FR 0411810A FR 0411810 A FR0411810 A FR 0411810A FR 2877573 B1 FR2877573 B1 FR 2877573B1
Authority
FR
France
Prior art keywords
pharmaceutical compositions
different forms
new pharmaceutical
drug accumulation
uses therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0411810A
Other languages
English (en)
French (fr)
Other versions
FR2877573A1 (fr
Inventor
Mario Sanchez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Debussy Holding SA
Original Assignee
Debussy Holding SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0411810A priority Critical patent/FR2877573B1/fr
Application filed by Debussy Holding SA filed Critical Debussy Holding SA
Priority to CNA2005800448695A priority patent/CN101087603A/zh
Priority to AU2005300424A priority patent/AU2005300424A1/en
Priority to EP05816959A priority patent/EP1814542A2/fr
Priority to PCT/FR2005/002775 priority patent/WO2006048560A2/fr
Priority to JP2007539613A priority patent/JP2008519016A/ja
Priority to US11/666,981 priority patent/US20080090895A1/en
Priority to RU2007120707/15A priority patent/RU2007120707A/ru
Priority to CA002586277A priority patent/CA2586277A1/fr
Publication of FR2877573A1 publication Critical patent/FR2877573A1/fr
Application granted granted Critical
Publication of FR2877573B1 publication Critical patent/FR2877573B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Addiction (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
FR0411810A 2004-11-05 2004-11-05 Nouvelles compositions pharmaceutiques et leurs utilisations pour lutter contre les differentes formes d'accoutumance aux drogues Expired - Fee Related FR2877573B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR0411810A FR2877573B1 (fr) 2004-11-05 2004-11-05 Nouvelles compositions pharmaceutiques et leurs utilisations pour lutter contre les differentes formes d'accoutumance aux drogues
AU2005300424A AU2005300424A1 (en) 2004-11-05 2005-11-07 Novel pharmaceutical compositions and the uses thereof for controlling the different forms of addiction to drugs
EP05816959A EP1814542A2 (fr) 2004-11-05 2005-11-07 Nouvelles compositions pharmaceutiques et leurs utilisations pour lutter contre les differentes formes d'accoutumance aux drogues
PCT/FR2005/002775 WO2006048560A2 (fr) 2004-11-05 2005-11-07 Nouvelles compositions pharmaceutiques et leurs utilisations pour lutter contre les differentes formes d'accoutumance aux drogues
CNA2005800448695A CN101087603A (zh) 2004-11-05 2005-11-07 新型药物组合物及其用于对抗不同形式的药物成瘾的用途
JP2007539613A JP2008519016A (ja) 2004-11-05 2005-11-07 新規な医薬品組成物および様々な形の薬物嗜癖を制御するためのそれらの使用
US11/666,981 US20080090895A1 (en) 2004-11-05 2005-11-07 Novel Pharmaceutical Composition And Their Uses Thereof For Controlling The Different Forms Of Addiction To Drugs
RU2007120707/15A RU2007120707A (ru) 2004-11-05 2005-11-07 Новые фармацевтические композиции и их применение для борьбы против различных форм привыкания к лекарствам
CA002586277A CA2586277A1 (fr) 2004-11-05 2005-11-07 Nouvelles compositions pharmaceutiques et leurs utilisations pour lutter contre les differentes formes d'accoutumance aux drogues

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0411810A FR2877573B1 (fr) 2004-11-05 2004-11-05 Nouvelles compositions pharmaceutiques et leurs utilisations pour lutter contre les differentes formes d'accoutumance aux drogues

Publications (2)

Publication Number Publication Date
FR2877573A1 FR2877573A1 (fr) 2006-05-12
FR2877573B1 true FR2877573B1 (fr) 2007-02-02

Family

ID=34953312

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0411810A Expired - Fee Related FR2877573B1 (fr) 2004-11-05 2004-11-05 Nouvelles compositions pharmaceutiques et leurs utilisations pour lutter contre les differentes formes d'accoutumance aux drogues

Country Status (9)

Country Link
US (1) US20080090895A1 (enExample)
EP (1) EP1814542A2 (enExample)
JP (1) JP2008519016A (enExample)
CN (1) CN101087603A (enExample)
AU (1) AU2005300424A1 (enExample)
CA (1) CA2586277A1 (enExample)
FR (1) FR2877573B1 (enExample)
RU (1) RU2007120707A (enExample)
WO (1) WO2006048560A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1988883A1 (fr) * 2006-02-17 2008-11-12 Trimaran Limited Nouvelles compositions pharmaceutiques destinees a optimiser des traitements de substitution et elargir la pharmacopee au traitement global des addictions
CN118593482A (zh) 2017-12-05 2024-09-06 赛诺维信制药公司 非外消旋混合物及其用途
AU2020286441A1 (en) 2019-06-04 2022-01-06 Sunovion Pharmaceuticals Inc. Modified release formulations and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4129655A (en) * 1976-04-26 1978-12-12 Ciba-Geigy Corporation Neuroleptic 2-piperidinoalkyl-1,4-benzodioxans
US4412999A (en) * 1982-04-14 1983-11-01 Merck & Co., Inc. Anti-emetic esters of cyproheptadine-3-carboxylic acid and structurally related compounds
US5994392A (en) * 1988-02-26 1999-11-30 Neuromedica, Inc. Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
WO1997035585A1 (en) * 1996-03-25 1997-10-02 Eli Lilly And Company Anesthetic method
MXPA04007936A (es) * 2002-02-15 2004-11-26 Upjohn Co Compuestos de aril-sustituidos para el tratamiento de enfermedades.

Also Published As

Publication number Publication date
JP2008519016A (ja) 2008-06-05
EP1814542A2 (fr) 2007-08-08
CN101087603A (zh) 2007-12-12
RU2007120707A (ru) 2008-12-10
AU2005300424A1 (en) 2006-05-11
CA2586277A1 (fr) 2006-05-11
WO2006048560A3 (fr) 2006-07-06
WO2006048560A2 (fr) 2006-05-11
FR2877573A1 (fr) 2006-05-12
US20080090895A1 (en) 2008-04-17

Similar Documents

Publication Publication Date Title
EP1765379A4 (en) PHARMACEUTICAL CO-CRYSTAL COMPOSITIONS AND RELEVANT USE METHOD
FR14C0020I1 (fr) Compositions pharmaceutiques contenant du fentanyl pour application nasale
EP2066350A4 (en) STABILIZED ANTIBODY FORMULATIONS AND THEIR USES
EP1748765A4 (en) Pharmaceutical suspension composition
EP1929073A4 (en) PROTEIN MEDICAMENT AND ITS USE
ZA200702536B (en) Low oil emulsion compositions for delivering taxolds and other insoluble drugs
ZA200809002B (en) Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
IL208497A0 (en) Pharmaceutical compositions containing erythropoietin and derivatives thereof
AP2008004671A0 (en) Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
EP1919288A4 (en) MEDICAMENTS CONTAINING FAMOTIDINE AND IBUPROFEN, AND ADMINISTRATION OF SAID DRUGS
IL183986A0 (en) Pharmaceutical compounds and compositions
EP1747004A4 (en) PHARMACEUTICAL COMPOSITIONS FOR METABOLISM CONDITIONS
ZA200609890B (en) Injectable pharmaceutical suspension comprising posaconazole
MA28862B1 (fr) Composition pharmaceutique sous forme de comprime a residence gastrique contenant un principe actif
DE602005004039D1 (de) Nicht-peptidische bradykinin-antagonisten und pharmazeutische zusammensetzungen daraus
FR2900823B1 (fr) Nouvelle forme d'administration du racecadotril.
EP1819323A4 (en) PHARMACEUTICAL COMPOSITION WITH ANTI-SKIN COMPOSER
IL178067A0 (en) Pharmaceutical dosage forms and compositions
FR2877573B1 (fr) Nouvelles compositions pharmaceutiques et leurs utilisations pour lutter contre les differentes formes d'accoutumance aux drogues
MA28603B1 (fr) Composition pharmaceutique antimycobacterienne
IL188848A (en) A transient receptor antagonist (TRPVI) i, a pharmaceutical preparation containing it for the treatment of related diseases and conditions.
EP1968609A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE USE OF HIGHLY LIPOPHILIC SULFHYDRYL COMPOUNDS
FR2888748B1 (fr) Composes neuroprotecteurs et compositions pharmaceutiques les comprenant
EP1758577A4 (en) NEW COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHOD OF ADMINISTRATION THEREFOR
EP2121596A4 (en) ATORVASTATIN STRONTIUM SALT AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse

Effective date: 20120731